Professor at Shanxi Medical University, China
Dr. Qin Xiaojiang is a distinguished professor and doctoral supervisor at Shanxi Medical University, China, where he also serves as the Associate Director of the Department of Science and Technology. With extensive experience in academic leadership and scientific research, he has made a profound impact in the fields of vascular toxicology, environmental exposure, and natural product pharmacology. Dr. Qin also directs the Institute of Environmental Exposure and Vascular Diseases and plays a pivotal role in guiding the Shanxi Provincial Science & Technology Innovation Team. His academic endeavors and leadership contributions have established him as a key figure in medical science research both nationally and internationally.
Profile
Orcid
Scopus
Education
Dr. Qin earned his Ph.D. in Medicine from Shanxi Medical University, where he built a strong foundation in clinical and translational medical research. Further advancing his global academic footprint, he completed a prestigious visiting scholar program at the University of California, San Francisco (UCSF) between 2019 and 2020. His international training enriched his scientific perspective and fostered interdisciplinary collaborations, especially in environmental health and vascular biology.
Experience
Over the years, Dr. Qin has accumulated a wealth of experience in both academic and administrative roles. As the Associate Director of the Department of Science and Technology at Shanxi Medical University, he has overseen various high-impact research initiatives and institutional advancements. He also leads the Institute of Environmental Exposure and Vascular Diseases, where his team conducts pioneering research on the vascular impacts of environmental pollutants. His leadership extends to regional innovation efforts, guiding the Shanxi Provincial Science & Technology Innovation Team in advancing biomedical discoveries.
Research Interest
Dr. Qin’s research primarily explores the pathogenic mechanisms of vascular toxicity resulting from environmental exposures, including tobacco-related and industrial pollutants. He is also deeply involved in the development of population-level tobacco control strategies to mitigate public health risks. Another cornerstone of his research lies in drug discovery derived from bioactive natural products, with the goal of identifying novel therapeutic agents with minimal adverse effects. His interdisciplinary approach bridges molecular toxicology, epidemiology, and pharmacognosy.
Award
Dr. Qin’s scientific excellence has been acknowledged through various grants and leadership recognitions. He has successfully secured three prestigious National Natural Science Foundation of China (NSFC) grants as Principal Investigator, affirming the national importance of his research. Additionally, he has led or co-led more than a dozen provincial, ministerial, and industry-sponsored research projects, underlining his capability in driving innovation and collaborative research in the life sciences.
Publication
Dr. Qin has published extensively, with 69 peer-reviewed articles in SCI/EI-indexed and core journals. His publications reflect his depth of inquiry into toxicological mechanisms and therapeutic discoveries. Select publications include:
-
Toxicology and Applied Pharmacology (2018) – cited by 42 articles.
-
Biomedicine & Pharmacotherapy (2019) – cited by 36 articles.
-
Environmental Research (2020) – cited by 28 articles.
-
Journal of Ethnopharmacology (2021) – cited by 25 articles.
-
Frontiers in Pharmacology (2022) – cited by 21 articles.
-
Scientific Reports (2020) – cited by 19 articles.
-
International Journal of Molecular Sciences (2023) – cited by 15 articles.
In addition to research papers, he holds two authorized invention patents and ten utility model patents, showcasing his innovation in translational research and applied technologies.
Conclusion
In conclusion, Dr. Qin Xiaojiang embodies the values of excellence in academic research, innovation, and scientific leadership. His deep commitment to understanding and combating vascular diseases through environmental toxicology and natural product pharmacology has yielded important scientific insights and public health applications. With a robust publication record, international research exposure, and multiple prestigious project leaderships, he stands as an exemplary candidate for any recognition in scientific achievement. His work not only advances medical science but also contributes meaningfully to community health and technological progress.